Back to today’s briefing

Story perspectives

FDA Approves First At-Home Cervical Cancer Test

5/12/2025

43 9

Summary

Story summary

The FDA has made a groundbreaking move by approving the Teal Wand, the first at-home cervical cancer screening test. Women aged 25-65 can now collect samples in the comfort of their homes and send them for analysis, breaking down barriers for those wary of traditional Pap smears. Launching in California next month, efforts are underway to secure insurance coverage.

1 of 1

Story summary

The FDA has made a groundbreaking move by approving the Teal Wand, the first at-home cervical cancer screening test. Women aged 25-65 can now collect samples in the comfort of their homes and send them for analysis, breaking down barriers for those wary of traditional Pap smears. Launching in California next month, efforts are underway to secure insurance coverage.